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Localization of the gene for X-Iinked Alport's syndrome. X-chromo-
somal DNA probes defining various polymorphic DNA markers were
used to study genetic linkage in three families with Alport's syndrome.
With the DXS17 marker, only a single cross-over was observed in 26
informative meioses, and evidence for linkage was also obtained with
the DXS 11 marker. These data localize the gene for the X-linked form
of Alport's syndrome to the middle of the long arm of the X chromo-
some.
Alport's syndrome is characterized by hereditary glomerulo-
nephritis and sensorineural deafness. The renal disease is
progressive, with end-stage renal failure usually before age 40 in
males. In females the course of the disease is much less severe
and less commonly requires renal replacement therapy. A
diagnosis of Alport's syndrome has been reported in 0.7 to 2.3%
of renal transplantation patients [1, 21. The genetics of Alport's
syndrome has been the subject of much discussion [3—5]. It is
generally held that this disorder is heterogeneous and may
consist of several separate genetic entities. X-linked inheritance
may explain the majority of pedigrees [6, 71. Male to male
transmission in some families strongly argues for the existence
of autosomal dominant forms, some of which may be distin-
guishable from the X-linked variety by the presence of macro-
thrombocytopathic thrombopenia [8, 9]. Evidence for a rare
autosomal recessive variety was presented by Feingold et al in
four families where affected siblings were born to normal
consanguinous parents [6]. In recent years enough DNA mark-
ers have been identified and regionally assigned on the human
X-chromosome to localize virtually any X-linked gene defect
[10]. For many X-linked disorders, closely-linked DNA mark-
ers are already available which can be used for detection of
carriers and presymptomatic patients. Moreover, identification
of such markers provides the first step towards actual isolation
and characterization of the defective gene. In order to localize
the gene defect underlying Alport's syndrome, we have per-
formed linkage studies in three unrelated families employing
various restriction fragment length polymorphisms (RFLPs),
defined by a set of regionally-mapped DNA probes.
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Methods
The patients studied belong to three unrelated Dutch and
German families with Alport's syndrome. In all three families,
the mode of transmission was compatible with an X-linked
inheritance. Renal biopsy was performed in at least one affected
subject in each family. Biopsies showed irregularity of the
glomerular basement membrane with splitting and intramem-
braneous granules, confirming the clinical diagnosis. All sub-
jects in the study were repeatedly evaluated for hematuria,
using the method of Gadeholt [11]. Audiographic testing was
performed in all patients and most of the relatives. Pedigrees
are shown in Figure 1. DNA was extracted from leucocytes of
EDTA-anticoagulated venous blood by standard procedures
[12]. Four micrograms of genomic DNA was digested with the
appropriate restriction enzymes under conditions as specified
by the manufacturer (Boehringer, Mannheim, FRG). DNA
fragments were electrophoresed in 0.7% agarose gels and
transferred to Gene-screen (New England Nuclear Boston,
Massachusetts, USA) membranes by Southern blotting [13].
Hybridization analysis was as described [14]. Autoradiography
was performed for three days at —70°C using double intensify-
ing screens. For linkage analysis a recent version (3.5) of the
LINKAGE program package was employed, which was pro-
vided by Dr. Jurg Ott (Zurich, Switzerland). In all calculations,
penetrance was assumed to be 85% in females. In males,
penetrance was assumed to be complete [15, 16].
Results
A total of 54 persons were tested. Results are given in Table
1 as lod scores, a logarithmic scale for the likelihood of linkage
to a genetic marker at a given recombination fraction. In our
material the highest lod score was found for the DXS 17 locus
defined by probe S9 [17]. The maximal value was 3.63 at a
recombination fraction of 0.04, indicating over 4000:1 odds for
linkage to this site. Only one cross-over was observed with the
DXS17 marker in 26 informative meioses. The 95% confidence
limits for the recombination fraction are 0.002 to 0.19. Positive
lod scores were also found for DXS 11, another marker near
DXS17 in the middle of the long arm of the chromosome. No
cross-over was observed with this marker in five meioses. The
other DNA markers showed loose or no linkage to the gene for
Alport syndrome.
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Fig. 1. Pedigrees. Upper left panel,
hematuria; upper right panel, renal
ii insufficiency. Lower left panel, hearing loss;
lower right panel: ocular abnormalities. *
Denotes renal biopsy. Persons marked —
I were evaluated for hematuria by quantitative
measurements.
Table 1. Tw0-point linkage analysis between RFLP'S and X-linked Alport's syndrome
Locus
.
Regional
localization
Lod scores at different recombination fractions
0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 0.45
DXS7
DXYSI
DXS17
DXSI1
DXS37
XplI.3
Xq13-2l
Xq21.3-22
Xq24-26
Xq26-27
—-
—-
—-
1.50
—---
—1.79
—1.45
3.62
1.39
—1,89
—0.92
—0.68
3.37
1.27
—0,27
—0.46 —0.18 —0.01 0,08
—0.29 —0.07 0.05 0.12
2.98 2.50 1.96 1.39
1.15 1.02 0.88 0.73
0.44 0.78 0.90 0.87
0.12
0.13
0.81
0,57
0.72
0.12
0.12
0.32
0,39
0.49
0.08
0.07
0.04
0.20
0.23
Abbreviations are: RFLP's, restriction fragment length polymorphisms; Lod score, logarithm of odds score; Xp and Xq refer to the short and
long arm of the X chromosome. Localizations are given as cytogenetic bands.
Significant linkage is indicated by a Lod score of greater than 3 between DXS17 and the Alport gene. Negative Lod scores argue against tight
linkage with DXS7, DXYS1 and DXS37.
Discussion
Based on linkage with DXS 1 (Zmax = 2.57 at 0max = 0.25)and
DXS3 (Zmax = 7.66 at 0.22), a location of the Alport
gene near the centromere has been proposed by Menlove et a!
[18]. Our results indicate that the Alport gene is closely linked
to the DXS17 marker (Zmax = 3.63 at Omax = 0.04). This argues
for a location in the vicinity of the Xq22 band, which is more
distal on the long arm (Fig. 2). This is corroborated by
multipoint linkage studies of our data, which exclude the Alport
gene from the Xpl l-Xq13 interval (Figure 3). A location of the
Alport gene at Xq22 would also explain the loose linkage to
more proximal Xq markers reported by Menlove et al [18].
Formal proof of X-linkage can be very difficult to obtain
unless very large families are studied. Although several inves-
tigators have proposed that an X-linked variety of Alport's
syndrome exists, compelling evidence for X-linkage has only
been obtained in one large Utah kindred [161. In the present
study, tight linkage with X-chromosomal markers argues for
X-linkage in all three of our Alport families. This illustrates
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Localization Relative likelihood
DXS7
DXYS1
DXS17
0.0039
0.1437
DXS11 1.0000
DXS37
Fig. 3. Relative likelihood of various genetic localizations of the Alport
gene. Likelihoods were calculated using the Linkmap program, which
varies the position of the disease gene relative to a fixed genetic map of
marker loci. Optimal fit was obtained by placing the Alport gene within
the DXS17-DXS37 interval, coinciding with the position of the DXSI I
marker. A relative likelihood of 0.0039 excludes the Alport gene from
the Xpl l-Xq13 segment defined by markers DXS7 and DXYS 1.
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that, in the future, the demonstration or exclusion of linkage
with suitable genetic markers should enable us to distinguish X
chromosomal from autosomal forms of this disorder, even in
small pedigrees. It will be intriguing to see whether X-linked
dominant inheritance accounts for the majority of Alport cases,
as has been suggested [6]. Male to male transmission is usually
interpreted as excluding X chromosomal inheritance. However,
it has been shown that a small portion of the X chromosome can
recombine with the Y chromosome during meiosis. This pseu-
do-autosomal region is located on the tip of the short arm of the
X chromosome (Xp). Recently, a functional gene has been
mapped to this region, indicating that pseudo-autosomal inher-
itance (that is, sex-linkage with occasional male to male trans-
mission) does occur in man [19].
Pseudo-autosomal inheritance has been proposed by Perkoff
et al [3] to explain anomalous segregation patterns in families
with Alport's syndrome. The localization of the Alport gene in
the middle of Xq disproves this assumption unless a second
pseudo-autosomal region is proposed to exist, which seems
unlikely in the light of studies on chromosome pairing during
meiosis [201. Therefore, simple autosomal dominant inheritance
remains the best explanation in those families where male to
male transmission of Alport's syndrome is evident. However,
care should be taken in these families to exclude other expla-
nations (such as faulty diagnosis) for the apparent male to male
transmission before discarding the possibility of X-linkage. To
the best of our knowledge, none of these families has been
studied with X-chromosomal markers.
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